AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimisil-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sansill Formulations

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimisil-M1 Tablet SR

DiabetaComb SR tablets are antidiabetic medications combining two active ingredients for managing type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. DiabetaComb SR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with seemingly controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb damage. This medication is one element of a comprehensive diabetes management plan, including a doctor-recommended diet, exercise, and weight management; lifestyle adjustments are vital for successful control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, presenting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women should seek medical counsel. Regular blood glucose checks and periodic blood tests (blood cell counts, liver function) are recommended under physician supervision.

Uses of Glimisil-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimisil-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisil-M1 Tablet SR with a meal.

Common Side effects of Glimisil-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimisil-M1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisil-M1 Tablet SR with a meal.

How Glimisil-M1 Tablet SR works:

Glimisil-M1 SR tablets contain a dual-action formulation of glimepiride and metformin, both agents used in diabetes management. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimisil-M1 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimisil-M1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimisil-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimisil-M1 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimisil-M1 SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimisil-M1 Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimisil-M1 Tablet SR :

Should you forget to take your Glimisil-M1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimisil-M1 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glimisil-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimisil-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimisil-M1 Tablet SR and seek immediate medical attention.
Glimisil-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimisil-M1 SR tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimisil-M1 Tablet SR use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, yearly supplemental Vitamin B12 is recommended by some researchers.
Glimisil-M1 SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimisil-M1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimisil-M1 Tablet SR
41
MRP 50
18% off